CCK‐JMV‐180 acts as an antagonist of the CCK<sub>A</sub> receptor in the human IMR‐32 neuroblastoma cell linePaul Schaeffer, Jean Marc Herbert, V. Prabonnaud et al.|FEBS Letters|1994Cited by 6